Chapter 12: Systematic review of prognostic tests

Journal of General Internal Medicine

Volumn 27, Issue SUPPL.1, 2012, Pages

  Rector, Thomas S ^a,b   Taylor, Brent C ^a,b   Wilt, Timothy J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

predictive accuracy; prognosis; reclassification; review

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL DECISION MAKING; DIAGNOSTIC TEST; HUMAN; OUTCOME ASSESSMENT; PATIENT CODING; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; COMPARATIVE EFFECTIVENESS RESEARCH; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; PROGNOSIS; REVIEW LITERATURE AS TOPIC;

EID: 84862661851     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1899-y     Document Type: Review

References (50)

1. H Janes MS Pepe PM Bossuyt WE Barlow 2011 Measuring the performance of markers for guiding treatment decisions Ann Intern Med 154 253 259 21320940
2. MA Hlatky P Greenland DK Arnett, et al. 2009 Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 17 2408 2416 19364974 10.1161/CIRCULATIONAHA. 109.192278
3. TJ Wang 2011 Assessing the role of circulating, genetic and imaging biomarkers in cardiovascular risk prediction Circulation 123 551 565 21300963 10.1161/CIRCULATIONAHA.109.912568
4. BJ Ingui MA Rogers 2001 Searching for clinical prediction rules in MEDLINE J Am Med Inform Assoc 8 4 391 397 11418546 10.1136/jamia.2001.0080391 1:STN:280:DC%2BD3MzlslOhuw%3D%3D
5. JA Hayden P Cote C Bombardier 2006 Evaluation of the quality of prognosis studies in systematicreviews Ann Intern Med 144 6 427 437 16549855
6. LM McShane DG Altman W Sauerbrei, et al. 2005 Reporting recommendations for tumor markerprognostic studies (REMARK) J Natl Cancer Inst 97 16 1180 1184 16106022 10.1093/jnci/dji237 1:CAS:528:DC%2BD2MXpsVaks7s%3D
7. RD Riley KR Abrams AJ Sutton, et al. 2003 Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future Br J Cancer 88 8 1191 1198 12698183 10.1038/sj.bjc. 6600886 1:STN:280:DC%2BD3s7nvVGhug%3D%3D
8. PA Kyzas D Denaxa-Kyza JP Ioannidis 2007 Almost all articles on cancer prognostic markers report statistically significant results Eur J Cancer 43 17 2559 2579 17981458 10.1016/j.ejca.2007.08.030
9. PA Kyzas KT Loizou JP Ioannidis 2005 Selective reporting biases in cancer prognostic factor studies J Natl Cancer Inst 97 14 1043 1055 16030302 10.1093/jnci/dji184
10. DG Altman 2001 Systematic reviews of evaluations of prognostic variables BMJ 323 7306 224 228 11473921 10.1136/bmj.323.7306.224 1:STN:280: DC%2BD3MvislWntQ%3D%3D
11. PA Hall JJ Going 1999 Predicting the future: a critical appraisal of cancer prognosis studies Histopathology 35 6 489 494 10583572 10.1046/j.1365-2559.1999.00862.x 1:STN:280:DC%2BD3c%2FltVOisg%3D%3D
12. DG Altman RD Riley 2005 Primer: an evidence-based approach to prognostic markers Nat Clin Pract Oncol 2 9 466 472 16265015 10.1038/ncponc0287
13. Speight PM. Assessing the methodological quality of prognostic studies. Chapter 3 (p. 7-13) In: Speight, Palmer, Moles, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 2006;10(14):1-144, iii-iv.
14. MS Pepe Z Feng H Janes, et al. 2008 Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design J Natl Cancer Inst 100 20 1432 1438 18840817 10.1093/jnci/djn326 1:CAS:528:DC%2BD1cXht1Oisb7P
15. H Janes MS Pepe 2008 Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting Am J Epidemiol 168 1 89 97 18477651 10.1093/aje/kwn099
16. JH Ware 2006 The limitations of risk factors as prognostic tools N Engl J Med 355 25 2615 2617 17182986 10.1056/NEJMp068249 1:CAS:528:DC%2BD28XhtlGhtLvO
17. MS Pepe H Janes G Longton, et al. 2004 Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker Am J Epidemiol 159 9 882 890 15105181 10.1093/aje/kwh101
18. Z Feng R Prentice S Srivastava 2004 Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective Pharmacogenomics 5 6 709 719 15335291 10.1517/14622416.5.6.709 1:CAS:528:DC%2BD2cXmvFOmtLc%3D
19. O Riesterer L Milas KK Ang 2007 Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy J Clin Oncol 25 26 4075 4083 17827456 10.1200/JCO.2007.11.8497 1:CAS:528: DC%2BD2sXhtlKqsbrO
20. MK Parmar V Torri L Stewart 1998 Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 24 2815 2834 9921604 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID- SIM110>3.0.CO;2-8 1:STN:280:DyaK1M7itVWksA%3D%3D
21. The Fibrinogen Studies Collaboration 2009 Measures to assess the prognostic ability of the stratified Cox proportional hazards model Stat Med 28 3 389 411 10.1002/sim.3378
22. CC Earle B Pham GA Wells 2000 An assessment of methods to combine published survival curves Med Decis Making 20 1 104 111 10638543 10.1177/0272989X0002000113 1:STN:280:DC%2BD3c7gt1Srsw%3D%3D
23. SE Coplen EM Antman JA Berlin, et al. 1990 Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials Circulation 82 4 1106 1116 2144796 10.1161/01.CIR.82.4.1106 1:STN:280:DyaK3czotFyltQ%3D%3D
24. T Sinuff NK Adhikari DJ Cook, et al. 2006 Mortality predictions in the intensive care unit: comparing physicians with scoring systems Crit Care Med 34 3 878 885 16505667 10.1097/01.CCM.0000201881.58644.41
25. HF Groenveld JL Januzzi K Damman, et al. 2008 Anemia and mortality in heart failure patients: a systematic review and meta-analysis J Am Coll Cardiol 52 10 818 827 18755344 10.1016/j.jacc.2008.04.061
26. WJ Mackillop CF Quirt 1997 Measuring the accuracy of prognostic judgments in oncology J Clin Epidemiol 50 1 21 29 9048687 10.1016/S0895-4356(96)00316-2 1:STN:280:DyaK2s3gtVymug%3D%3D
27. E Ingelsson EJ Schaefer JH Contois, et al. 2007 Clinical utility of different lipid measures for prediction of coronary heart disease in men and women JAMA 298 7 776 785 17699011 10.1001/jama.298.7.776 1:CAS:528: DC%2BD2sXpt1enurg%3D
28. RM Poses RD Cebul M Collins, et al. 1986 The importance of disease prevalence in transporting clinical prediction rules. The case of streptococcal pharyngitis Ann Intern Med 105 4 586 591 3530079 1:STN:280:DyaL28zitFCnug%3D%3D
29. NR Cook 2007 Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 7 928 935 17309939 10.1161/ CIRCULATIONAHA.106.672402
30. MS Pepe HE Janes 2008 Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer J Natl Cancer Inst 100 14 978 979 18612128 10.1093/jnci/djn215 1:CAS:528:DC%2BD1cXoslGgtrc%3D
31. Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford, UK: Oxford University Press; 2003. Section 9.2, Incorporating the time dimension; p. 259-67.
32. MJ Pencina RB D'Agostino 2004 Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 13 2109 2123 15211606 10.1002/sim.1802
33. MS Pepe Y Zheng Y Jin, et al. 2008 Evaluating the ROC performance of markers for future events Lifetime Data Anal 14 1 86 113 18064569 10.1007/s10985-007-9073-x
34. SM Grundy JI Cleeman CN Merz, et al. 2004 Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2 227 239 15249516 10.1161/01.CIR.0000133317.49796. 0E
35. NR Cook PM Ridker 2009 Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures Ann Intern Med 150 11 795 802 19487714
36. H Janes MS Pepe W Gu 2008 Assessing the value of risk predictions by using risk stratification tables Ann Intern Med 149 10 751 760 19017593
37. Ankle Brachial Index Collaboration FG Fowkes GD Murray, et al. 2008 Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis JAMA 300 2 197 208 18612117 10.1001/jama.300.2.197 1:CAS:528:DC%2BD1cXosVeit7o%3D
38. JB Meigs P Shrader LM Sullivan, et al. 2008 Genotype score in addition to common risk factors for prediction of type 2 diabetes N Engl J Med 359 21 2208 2219 19020323 10.1056/NEJMoa0804742 1:CAS:528:DC%2BD1cXhtl2gurnE
39. JG Pigeon JF Heyse 1999 An improved goodness of fit statistic for probability prediction models Biom J 41 1 71 82 10.1002/(SICI)1521-4036(199903) 41:1<71::AID-BIMJ71>3.0.CO;2-O
40. MJ Pencina RB D'Agostino Sr RB D'Agostino Jr, et al. 2008 Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2 157 172 17569110 10.1002/sim.2929 discussion 207-12
41. MJ Pencina RB D'Agostino Sr EW Steyerberg 2011 Extensions of net reclassifcation improvement calculations to measure usefulness of new biomarkers Stat Med 30 11 21 21204120 10.1002/sim.4085
42. CS Moskowitz MS Pepe 2006 Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs Clin Trials 3 3 272 279 16895044 10.1191/1740774506cn147oa
43. W Leisenring T Alonzo MS Pepe 2000 Comparisons of predictive values of binary medical diagnostic tests for paired designs Biometrics 56 2 345 351 10877288 10.1111/j.0006-341X.2000.00345.x 1:STN:280:DC%2BD3cvotVyntA%3D%3D
44. E Graf C Schmoor W Sauerbrei, et al. 1999 Assessment and comparison of prognostic classification schemes for survival data Stat Med 18 17-18 2529 2545 10474158 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529::AID-SIM274>3. 0.CO;2-5 1:STN:280:DyaK1MvgslSitg%3D%3D
45. P Royston W Sauerbrei 2004 A new measure of prognostic separation in survival data Stat Med 23 5 723 748 14981672 10.1002/sim.1621
46. Y Huang M Sullivan Pepe Z Feng 2007 Evaluating the predictiveness of a continuous marker Biometrics 63 4 1181 1188 17489968 10.1111/j.1541-0420.2007. 00814.x
47. MS Pepe Z Feng Y Huang, et al. 2008 Integrating the predictiveness of a marker with its performance as a classifier Am J Epidemiol 167 3 362 368 17982157 10.1093/aje/kwm305
48. AJ Vickers EB Elkin 2006 Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 6 565 574 17099194 10.1177/0272989X06295361
49. KB Dear 1994 Iterative generalized least squares for meta-analysis of survival data at multiple times Biometrics 50 4 989 1002 7787011 10.2307/2533438 1:STN:280:DyaK2Mzgs1Kjug%3D%3D
50. LR Arends MG Hunink T Stijnen 2008 Meta-analysis of summary survival curve data Stat Med 27 22 4381 4396 18465839 10.1002/sim.3311